C D OMalley
Overview
Explore the profile of C D OMalley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balasubramanian A, Wade S, Adler R, Lin C, Maricic M, OMalley C, et al.
Osteoporos Int
. 2016 Jun;
27(11):3239-3249.
PMID: 27273113
Introduction: We evaluated the impact of systemic glucocorticoid exposure on fracture risk among relatively young patients with new-onset rheumatoid arthritis (RA). Methods: Using administrative data, we identified 42,127 RA patients...
2.
Ferrari S, Adachi J, Lippuner K, Zapalowski C, Miller P, Reginster J, et al.
Osteoporos Int
. 2015 Jun;
26(12):2763-71.
PMID: 26068295
Unlabelled: Limited data exist on the efficacy of long-term therapies for osteoporosis. In osteoporotic postmenopausal women receiving denosumab for 7 years, nonvertebral fracture rates significantly decreased in years 4-7 versus...
3.
Manthripragada A, OMalley C, Gruntmanis U, Hall J, Wagman R, Miller P
Osteoporos Int
. 2015 Jan;
26(5):1619-27.
PMID: 25616508
Unlabelled: In this large retrospective study of men with presumed osteoporosis, we estimate the rate of osteoporosis-related fractures in men age ≥30 years. Our results suggest that spine and hip...
4.
LeBlanc E, Rosales A, Balasubramanian A, OMalley C, Egbuna O, Friess D, et al.
Osteoporos Int
. 2014 Oct;
26(2):713-25.
PMID: 25354654
Summary: Bisphosphonate therapy reduces fracture risk but does not eliminate fracture occurrence. We determined the fracture incidence and risk factors for fractures among 14,674 bisphosphonate users in a community setting....
5.
OMalley C, Tran N, Zapalowski C, Daizadeh N, Olenginski T, Cauley J
Osteoporos Int
. 2014 May;
25(8):2117-30.
PMID: 24859882
Unlabelled: To determine the incidence of comorbidities in women with and without osteoporosis, incidence rates per 1,000 person-years were calculated using electronic health records from an integrated healthcare system. The...
6.
Wade S, Strader C, Fitzpatrick L, Anthony M, OMalley C
Arch Osteoporos
. 2014 May;
9:182.
PMID: 24847682
Unlabelled: In nine industrialized countries in North America, Europe, Japan, and Australia, country-specific osteoporosis prevalence (estimated from published data) at the total hip or hip/spine ranged from 9 to 38 ...
7.
Reynolds K, Muntner P, Cheetham T, Harrison T, Morisky D, Silverman S, et al.
Osteoporos Int
. 2013 Apr;
24(9):2509-17.
PMID: 23595561
Unlabelled: We estimated primary non-adherence to oral bisphosphonate medication and examined the factors associated with primary non-adherence. Nearly 30% of women did not pick up their new bisphosphonate within 60...
8.
9.
10.
OMalley C, Magoun H
Riv Stor Sci
. 2009 Nov;
4(1):39-64.
PMID: 19928330
From man's earliest observations of apes the tendency has been to stress the degree of resemblance between human and anthropoid. Hanno (c. 500 BC) referred to the Gorillas as "savage...